News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • AAOI shares plunged following negative macro headlines.
  • The company announced a dilution event that further pressured the stock.
  • Revenue momentum persists in CATV and data-center optics segments.
  • Market capitalization fell to roughly $5.3 billion.
  • Analysts outlined a mid-term long trade with entry, stop, and target levels.
  • Primary near-term risk is further dilution from new share issuance.

Latest Articles

Costco Wholesale Corporation Reports September Sales Results

Costco Wholesale Corporation Reports September Sales Results

Costco Wholesale Corporation reported net sales of $30.02 billion for the five weeks ended October 4, 2026, marking a 13.0% year-over-year increase. Comparable sales grew 11.4% company-wide, with digital sales rising 19.0%. Growth was observed across the U.S., Canada, and international segments despite some effects from calendar shifts. The company…

Oil-Dri’s Board of Directors Appoints Anthony W. Parker as an Executive Officer and Declares Quarterly Dividends

Oil-Dri’s Board of Directors Appoints Anthony W. Parker as an Executive Officer and Declares Quarterly Dividends

Oil-Dri Corporation of America appoints Anthony W. Parker as an executive officer, recognizing his leadership and strategic counsel in legal and corporate governance matters. The company declares quarterly cash dividends of $0.225 per common share and $0.168 per Class B share, marking 23 years of consecutive annual dividend increases. Oil-Dri will …

Lifecore Biomedical to Participate at Upcoming Industry Conferences

Lifecore Biomedical to Participate at Upcoming Industry Conferences

Lifecore Biomedical, a Nasdaq-listed contract development and manufacturing organization specializing in injectable pharmaceutical products, announced its participation in three upcoming industry conferences in Boston. The company aims to engage with prospective customers to discuss its process development and manufacturing services, highlighting i…

Valley National Bancorp to Announce Third Quarter 2026 Earnings

Valley National Bancorp to Announce Third Quarter 2026 Earnings

Valley National Bancorp, a regional bank holding company with $66 billion in assets, announced its third quarter 2026 earnings release scheduled before market open on October 22, 2026. CEO Ira Robbins will discuss the results in a conference call and webcast. The company serves multiple states and provides consumer, commercial, and wealth managemen…

Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline

Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline

Alector, Inc. announced it will host a virtual event discussing advancements in its proprietary Alector Brain Carrier (ABC) blood-brain barrier platform and related therapeutic programs targeting neurodegenerative diseases. Key pipeline candidates include AL137, AL164, AL062, and ADP065, which focus on Alzheimer's and Parkinson's diseases through e…

MidCap Financial Investment Corporation Schedules Earnings Release and Conference Call for Quarter Ended September 30, 2026

MidCap Financial Investment Corporation Schedules Earnings Release and Conference Call for Quarter Ended September 30, 2026

MidCap Financial Investment Corporation, a NASDAQ-listed business development company managed by Apollo Investment Management, announced it will release its earnings for the quarter ended September 30, 2026, prior to market open on November 5, 2026. The company will host a conference call the same day to discuss results. MidCap focuses on investing…

Fortune Media and Great Place To Work® Name Credit Acceptance to 2026 Best Workplaces in Financial Services™ List for the 12th Consecutive Year

Fortune Media and Great Place To Work® Name Credit Acceptance to 2026 Best Workplaces in Financial Services™ List for the 12th Consecutive Year

Credit Acceptance Corporation has been recognized for the 12th consecutive year as one of the Best Workplaces in Financial Services & Insurance by Great Place To Work®, ranking 5th among large companies, highlighting its ongoing commitment to employee satisfaction, innovation, and strong business performance.

BCB Bancorp, Inc. Announces New Directors; Reorganization of C-Suite

BCB Bancorp, Inc. Announces New Directors; Reorganization of C-Suite

BCB Bancorp, Inc., the holding company for BCB Community Bank, announced the appointments of Steven E. Gallotta and Denny Kim to its board of directors, as well as Patricia M. Schaubeck as Executive Vice President, Chief Legal Officer and Corporate Secretary. These changes are part of a reorganization aimed at strengthening governance, risk managem…

McDonald's Dip: A Measured Buy for a 45‑Day Trade

McDonald's Dip: A Measured Buy for a 45‑Day Trade

McDonald's (MCD) is trading near its 52-week low after a pullback that punished growth expectations. The business still generates durable free cash flow ($7.385B trailing FCF) and pays a healthy ~3.2% dividend. For traders willing to accept operational execution risk, a controlled long with a $231 entry, $260 target and $222 stop balances upside fr…

Oracle: Earnings Acceleration Is Now Kicking In — Time a Swing Long

Oracle: Earnings Acceleration Is Now Kicking In — Time a Swing Long

Oracle looks like a good swing-long after recent stabilization around $140. The business is benefitting from a huge contracted AI backlog, improving cloud revenue dynamics and still-high profitability metrics. Valuation at roughly $435B market cap and a mid-20s P/E leaves room for multiple expansion if execution continues. Trade plan provided with …

SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies

SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies

SRX Global Inc. (NYSE American: SRXH) has entered into a definitive agreement to acquire CERo Therapeutics, an innovative immunotherapy company developing CER-1236, a next-generation engineered T cell therapy targeting hematologic malignancies. The acquisition will make CERo a wholly-owned subsidiary of SRX, providing enhanced capital access and op…